Trends in cause-specific readmissions in heart failure with preserved vs. reduced and mid-range ejection fraction

被引:14
作者
Cui, Xiaotong [1 ,2 ]
Thunstrom, Erik [2 ]
Dahlstrom, Ulf [3 ,4 ]
Zhou, Jingmin [1 ]
Ge, Junbo [1 ]
Fu, Michael [2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden
[3] Linkoping Univ, Dept Cardiol, Linkoping, Sweden
[4] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
来源
ESC HEART FAILURE | 2020年 / 7卷 / 05期
关键词
Heart failure; Readmission; Trends; Prognosis; ALL-CAUSE MORTALITY; OUTCOMES; ASSOCIATION; HOSPITALIZATION; CANDESARTAN; BORDERLINE;
D O I
10.1002/ehf2.12899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The aim of this study was to investigate whether the readmission of heart failure (HF) patients has decreased over time and how it differs among HF with preserved ejection fraction (EF) (HFpEF) vs. reduced EF (HFrEF) and mid-range EF (HFmrEF). Methods and results We evaluated HF patients index hospitalized from January 2004 to December 2011 in the Swedish Heart Failure Registry with 1 year follow-up. Outcome measures were the first occurring all-cause, cardiovascular (CV), and HF readmissions. A total of 20 877 HF patients (11 064 HFrEF, 4215 HFmrEF, and 5562 HFpEF) were included in the study. All-cause readmission was the highest in patients with HFpEF, whereas CV and HF readmissions were the highest in HFrEF. From 2004 to 2011, HF readmission rates within 6 months (from 22.3% to 17.3%,P = 0.003) and 1 year (from 27.7% to 23.4%,P = 0.019) in HFpEF declined, and the risk for 1 year HF readmission in HFpEF was reduced by 7% after adjusting for age and sex (P = 0.022). Likewise, risk factors for HF readmission in HFpEF changed. However, no significant changes were observed in all-cause or CV readmission rates in HFpEF, and no significant changes in cause-specific readmissions were observed in HFrEF. Time to the first readmission did not change significantly from 2004 to 2011, regardless of EF subgroup (all P-values > 0.05). Conclusions Declining temporal trend in HF readmission rates was found in HFpEF, but all-cause readmission still remained the highest in HFpEF vs. HFrEF and HFmrEF. More efforts are needed to reduce the non-HF-related readmission in patients with HFpEF.
引用
收藏
页码:2894 / 2903
页数:10
相关论文
共 27 条
  • [1] The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?
    Beutler, E
    Waalen, J
    [J]. BLOOD, 2006, 107 (05) : 1747 - 1750
  • [2] Trends in Length of Stay and Short-term Outcomes Among Medicare Patients Hospitalized for Heart Failure, 1993-2006
    Bueno, Hector
    Ross, Joseph S.
    Wang, Yun
    Chen, Jersey
    Vidan, Maria T.
    Normand, Sharon-Lise T.
    Curtis, Jeptha P.
    Drye, Elizabeth E.
    Lichtman, Judith H.
    Keenan, Patricia S.
    Kosiborod, Mikhail
    Krumholz, Harlan M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (21): : 2141 - 2147
  • [3] Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population
    Cheng, Richard K.
    Cox, Margueritte
    Neely, Megan L.
    Heidenreich, Paul A.
    Bhatt, Deepak L.
    Eapen, Zubin J.
    Hernandez, Adrian F.
    Butler, Javed
    Yancy, Clyde W.
    Fonarow, Gregg C.
    [J]. AMERICAN HEART JOURNAL, 2014, 168 (05) : 721 - 730
  • [4] The perindopril in elderly people with chronic heart failure (PEP-CHF) study
    Cleland, John G. F.
    Tendera, Michal
    Adamus, Jerzy
    Freemantle, Nick
    Polonski, Lech
    Taylor, Jacqueline
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2338 - 2345
  • [5] Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial
    Desai, Akshay S.
    Liu, Jiankang
    Pfeffer, Marc A.
    Claggett, Brian
    Fleg, Jerome
    Lewis, Eldrin F.
    McKinlay, Sonja
    O'Meara, Eileen
    Shah, Sanjiv J.
    Sweitzer, Nancy K.
    Solomon, Scott
    Pitt, Bertram
    [J]. JOURNAL OF CARDIAC FAILURE, 2018, 24 (05) : 313 - 320
  • [6] Rehospitalization for Heart Failure Predict or Prevent?
    Desai, Akshay S.
    Stevenson, Lynne W.
    [J]. CIRCULATION, 2012, 126 (04) : 501 - 506
  • [7] Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs
    DeVore, Adam D.
    Schulte, Phillip J.
    Mentz, Robert J.
    Hardy, N. Chantelle
    Kelly, Jacob P.
    Velazquez, Eric J.
    Maya, Juan F.
    Kielhorn, Adrian
    Patel, Harshali K.
    Reed, Shelby D.
    Hernandez, Adrian F.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (06) : 946 - 951
  • [8] Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge
    Dharmarajan, Kumar
    Wang, Yongfei
    Lin, Zhenqiu
    Normand, Sharon-Lise T.
    Ross, Joseph S.
    Horwitz, Leora I.
    Desai, Nihar R.
    Suter, Lisa G.
    Drye, Elizabeth E.
    Bernheim, Susannah M.
    Krumholz, Harlan M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (03): : 270 - 278
  • [9] Epidemiology of heart failure with preserved ejection fraction
    Dunlay, Shannon M.
    Roger, Veronique L.
    Redfield, Margaret M.
    [J]. NATURE REVIEWS CARDIOLOGY, 2017, 14 (10) : 591 - 602
  • [10] Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure
    Eklind-Cervenka, Maria
    Benson, Lina
    Dahlstrom, Ulf
    Edner, Magnus
    Rosenqvist, Marten
    Lund, Lars H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (02): : 175 - 182